US Stock MarketDetailed Quotes
GILD Gilead Sciences
- 66.760
- +0.600+0.91%
Close Apr 19 16:00 ET
- 66.660
- -0.100-0.15%
Post 19:59 ET
83.25BMarket Cap14.84P/E (TTM)
66.830High66.160Low10.66MVolume66.250Open66.160Pre Close709.78MTurnover0.86%Turnover Ratio14.84P/E (Static)1.25BShares86.97452wk High3.65P/B83.07BFloat Cap65.90052wk Low3.00Dividend TTM1.24BShs Float91.089Historical High4.49%Div YieldTTM1.01%Amplitude0.414Historical Low66.602Avg Price1Lot Size
About Gilead Sciences Company
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Company Profile
SymbolGILD
Company NameGilead Sciences
Listing DateJan 22, 1992
Issue Price15.00
Founded1987
CEOMr. Daniel P. O'Day
MarketNASDAQ
Employees18000
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address333 Lakeside Drive
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-574-3000
Websitehttp://www.gilead.com
Company Executives
- Name
- Position
- Salary
- Daniel O’Day
- Chairman of the Board and Chief Executive Officer
- --
- Daniel P. O'Day
- Chairman of the Board and Chief Executive Officer
- 22.61M
- Sandra Patterson
- Senior Vice President, Assistant Controller and Chief Accounting Officer
- --
- Johanna Mercier
- Chief Commercial Officer
- 8.59M
- Andrew D. Dickinson
- Chief Financial Officer
- 8.11M
- Dr. Merdad V. Parsey, M.D.,PhD
- Chief Medical Officer
- 8.39M
- Deborah H. Telman
- Executive Vice President, Corporate Affairs and General Counsel
- 5.27M
- Dr. Ted W. Love, M.D.
- Director
- --
- Kevin E. Lofton
- Lead Independent Director
- 507.44K
- Dr. Jacqueline K. Barton, PhD
- Independent Director
- 429.92K
- Dr. Sandra J. Horning, M.D.
- Independent Director
- 429.92K
- Kelly Anne Kramer
- Independent Director
- 434.92K
- Anthony Welters
- Independent Director
- 444.92K
- Jeffrey A. Bluestone
- Independent Director
- 409.92K
- Javier J. Rodriguez
- Independent Director
- 399.92K
- Harish Manwani
- Independent Director
- 414.92K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
